Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 3
ClinicalTrials.gov
A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR)
INTERVENTIONAL
Inicio: 28 de jun de 2024
ID: NCT06331312
Completado
Fase 2
ClinicalTrials.gov
A 48-week, 6-arm, Randomized, Double-blind, Placebo-controlled Multicenter Trial to Assess the Safety and Efficacy of Multiple CFZ533 Doses Administered Subcutaneously in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)
INTERVENTIONAL
Inicio: 1 de oct de 2019
ID: NCT03905525
Completado
ClinicalTrials.gov
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
OBSERVATIONAL
Inicio: 1 de may de 2012
ID: NCT01582763
Completado
Fase 3
ClinicalTrials.gov
Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies
INTERVENTIONAL
Inicio: 1 de sept de 2005
ID: NCT00720798
Completado
Fase 2
ClinicalTrials.gov
An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 2 to 17 Years, With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Followed by an Extension Phase
INTERVENTIONAL
Inicio: 6 de sept de 2016
ID: NCT02776735
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind Study of Safety and Reduction in Signs and Symptoms During Treatment With Tocilizumab Versus Placebo, in Combination With Methotrexate, in Patients With Moderate to Severe Rheumatoid Arthritis
INTERVENTIONAL
ID: NCT00106548
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlledTrial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously, in Methotrexate-naive Subjects With Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00264537
Por invitación
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirolizumab Pegol Treatment in Study Participants With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 27 de jul de 2021
ID: NCT04976322
Completado
Fase 2
ClinicalTrials.gov
A Phase II Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-range Finding Study to Evaluate the Safety and Efficacy of ALX-0061 Administered Subcutaneously in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 1 de jul de 2015
ID: NCT02437890
Completado
Fase 3
ClinicalTrials.gov
Biological Response of Stage IV Knee Osteoarthritis to Serial 12.5% Dextrose Injections Without Weight Bearing Restriction: A Double Arthroscopic Assessment
INTERVENTIONAL
Inicio: 1 de jul de 2010
ID: NCT01210183
Reclutando
Fase 2
ClinicalTrials.gov
A Multicentre, Parallel-group, Phase II, Randomised, Double-blind, 4 Arm Study to Evaluate Efficacy and Safety of AZD1163 in Participants With Moderately-to-Severely Active Rheumatoid Arthritis (LaunchPAD-RA)
INTERVENTIONAL
Inicio: 15 de dic de 2025
ID: NCT07276581
Por invitación
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label, Single-Arm, Phase 3, Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy
INTERVENTIONAL
Inicio: 3 de oct de 2023
ID: NCT06044337
Terminado
Fase 3
ClinicalTrials.gov
Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled Syringe or Auto Injector in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de sept de 2012
ID: NCT01676701
Terminado
Fase 2
ClinicalTrials.gov
A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed Protocol EMR-700461-023 (ADDRESS II)
INTERVENTIONAL
Inicio: 29 de jul de 2014
ID: NCT02070978
Reclutando
Fase 2
ClinicalTrials.gov
An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, With Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase
INTERVENTIONAL
Inicio: 9 de ago de 2018
ID: NCT02991469
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Double-Dummy Study Assessing The Safety and Tolerability of Sarilumab and Tocilizumab In Patients With Rheumatoid Arthritis Who Are Inadequate Responders to or Intolerant of TNF Antagonists
INTERVENTIONAL
Inicio: 1 de mar de 2013
ID: NCT01768572
Completado
Fase 4
ClinicalTrials.gov
PHASE 3B/4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR (TNF) INHIBITOR IN SUBJECTS WITH RHEUMATOID ARTHRITIS
INTERVENTIONAL
Inicio: 14 de mar de 2014
ID: NCT02092467
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 25 de jul de 2019
ID: NCT03978520
Completado
Fase 2
ClinicalTrials.gov
A Phase IIb, Randomized, Double-blind Study in Subjects With Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared With Placebo in Subjects With an Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 18 de sept de 2017
ID: NCT03233230
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Voclosporin (23.7 mg Twice Daily) With Placebo in Achieving Renal Response in Subjects With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 17 de may de 2017
ID: NCT03021499
Anterior
1
...
14
15
16
...
434
Siguiente
Filtros